Showing results (11-20 of 266) with videos related to
Sort By:
Pageof 27
Obesity (Silver Spring, Md.)|June 11, 2021
Senescent cells in human adipose tissue: A cross-sectional studyAna Elena Espinosa De Ycaza, Esben Søndergaard, Maria Morgan-Bathke, et al.Obesity (Silver Spring, Md.)|April 24, 2021
Adipocyte Proteins and Storage of Endogenous Fatty Acids in Visceral and Subcutaneous Adipose Tissue in Severe ObesityKelli A Lytle, Nikki C Bush, Jessica M Triay, et al.Advances in Nutrition (Bethesda, Md.)|November 15, 2015
Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancerDonald B Jump, Christopher M Depner, Sasmita Tripathy, et al.The Proceedings of the Nutrition Society|August 19, 2015
Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- miceDonald B Jump, Christopher M Depner, Sasmita Tripathy, et al.Pharmacology & Therapeutics|July 21, 2017
Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver diseaseDonald B Jump, Kelli A Lytle, Christopher M Depner, et al.Journal of Lipid Research|August 29, 2015
Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathwayKelli A Lytle, Christopher M Depner, Carmen P Wong, et al.Metabolites|October 31, 2019
A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male Ldlr MiceManuel García-Jaramillo, Kelli A Lytle, Melinda H Spooner, et al.Obesity (Silver Spring, Md.)|August 26, 2006
Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factorsMichael D JensenThe American Journal of Medicine|October 2, 2007
What is the potential role of cannabinoid-1 receptor blockade in glucose and lipid management?Michael D JensenEndocrinology and Metabolism Clinics of North America|May 19, 2020
Visceral Fat: Culprit or Canary?Michael D JensenPageof 27